Liver Function

Levels of AST/ALT in patients receiving Smoflipid® were significantly lower versus soybean oil emulsions7,18

liver functions

STUDY TAKEAWAY
Smoflipid® showed lower concentrations of liver enzymes (ALT, AST) compared to soybean oil lipid emulsions, indicating an improvement in the patient's liver function.7

Monitor liver function. If Smoflipid® treated patients develop liver enzyme abnormalities, consider discontinuation or dose reduction.


References

  1. Klek S, et al. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid): a double-blind, randomised, multicentre study in adults. Clin Nutr. 2013;32(2):224-231.
  1. Antébi H, et al. Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsions. JPEN J Parenter Enteral Nutr. 2004;28(3):142-148.